ClinicalTrials.Veeva

Menu

Role of the Intrapartum Grobman Nomogram in the Indication of Attempted Vaginal Delivery After Cesarean Section (GPP)

C

Central Hospital, Nancy, France

Status

Not yet enrolling

Conditions

Vaginal Delivery

Treatments

Other: data collection

Study type

Observational

Funder types

Other

Identifiers

NCT06202768
2023PI211

Details and patient eligibility

About

The rate of pregnant patients with a history of cesarean section is increasing. Caesarean section is a surgery which is not without risk and in particular concerning the risk of uterine rupture and malplacentation during a new pregnancy.

Considering the outcome of a new birth following a cesarean section is not easy. There is no reliable score to predict the success rate of vaginal delivery with a history of scarred uterus. The aim of our study would be to validate the intrapartum Grobman nomogram within the population of the Nancy University Hospital and thus to target the population for whom vaginal delivery could be offered.

Enrollment

800 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Vertex singleton pregnancy
  • Full-term delivery (beyond 37 weeks)
  • A history of cesarean section (segmental transverse scar)

Exclusion criteria

  • Fetal death in utero

Trial design

800 participants in 1 patient group

Main population
Description:
History of cesarean section Vertex singleton gestation At term (at least 37 weeks of gestation)
Treatment:
Other: data collection

Trial contacts and locations

1

Loading...

Central trial contact

Charlotte COTTEZ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems